Novartis Q2 2026 earnings beat as cancer, MS drugs drive growth

Stocks Yahoo Finance By Yahoo Finance 21 Jul 2026 13:24 1 min read

Novartis Q2 2026 earnings beat as cancer, MS drugs drive growth

Novartis Q2 2026 earnings beat as cancer, MS drugs drive growth

Novartis Q2 2026 earnings beat as cancer, MS drugs drive growth

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.